-
Mashup Score: 0Gaining the Patient’s Perspective: PROs in GVHD - 6 month(s) ago
Home > GVHD > Gaining the Patient’s Perspective: PROs in GVHD As the number of patients surviving allogeneic hematopoietic stem cell transplant and living with graft-versus-host disease (GVHD) increases, oncology nurses must hear patients to provide the best care possible. Understanding how patients and caregivers describe their health status is crucial to knowing what matters most to patients. One mechan ism to help collect valuable information—patients’ perceptions of symptoms, function, and quality of
Source: cancernursingtoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 6Cella Named 2023 Tripartite Prize Recipient - 8 month(s) ago
David Cella, PhD, professor of Medical Social Sciences, has been named the winner of the 2023 Tripartite Legacy Faculty Prize in Translational Science and Education.
Source: news.feinberg.northwestern.eduCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Join us in congratulating David Cella, PhD, Associate Director for Cancer Prevention and Control @LurieCancer, on winning the 2023 Tripartite Prize. Read about his trailblazing work amplifying the patient voice: https://t.co/SmjPFZNwaw #QoL #PROs https://t.co/D92VtIPvFh
-
-
Mashup Score: 0PROTEUS — Practice Guide | The Proteus Consortium - 10 month(s) ago
The PROTEUS-Practice Guide
Source: The Proteus ConsortiumCategories: Hem/Oncs, Latest HeadlinesTweet-
Design, Implement, Manage #PROs in clinical trials and in clinical practice. https://t.co/6RiDO0celW
-
-
Mashup Score: 0PROSPECT Trial (Alliance N1048): PROs During and After Treatment for Locally Advanced Rectal Cancer - 11 month(s) ago
Host Dr. Shannon Westin interviews guests Dr. Ethan Basch and Dr Deborah Schrag on their JCO simultaneous publication paper at ASCO’s 2023 annual meeting: “Patient-reported outcomes during and after treatment for locally advanced rectal cancer (Alliance N1048). TRANSCRIPT The Disclosure for guests on this podcast can be found in the show notes Dr. Shannon Westin: Hello, and welcome to another…
Source: directory.libsyn.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
New JCO After Hours Podcast 🎙️ 🗣️ Host @ShannonWestin interviews Drs. @EthanBasch1 & Deborah Schrag on their #ASCO23 JCO simultaneous publication on #PROs in @ALLIANCE_org N1048 Clinical Trial in #RectalCancer Listen➡️ https://t.co/UTWfcisk9d #SuppOnc #PallOnc #radonc #CRCSM https://t.co/cUWi9cpjid
-
-
Mashup Score: 0
New data from RAD 2023 revealed the results of assessing the independent and combined effects of itch and skin severity on patient-reported symptoms and QoL.
Source: Dermatology TimesCategories: Dermatology, Latest HeadlinesTweet-
Complete or almost complete relief of both #itch and skin #lesions is associated with an increased chance of achieving ideal states in patient-reported outcomes (#PROs) and the #Dermatology Life Quality Index, according to new data from #RAD2023. https://t.co/a2EZZDxyOx
-
-
Mashup Score: 4Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma - 1 year(s) ago
Myeloma AHCT survivors in stable remission have no clinically meaningful worsening in physical functioning compared to general population.. Survivorship programs should address ongoing distress due to health burden, uncertainty, and finances in myeloma survivors, along with targeted interventions for modifiable health behaviors such as nutrition and exercise.
Categories: Hem/Oncs, Latest HeadlinesTweet-
👍 @rajshekharucms for leading analysis of #PROs in #myeloma auto #BMT survivors @ASTCT_Journal: ⬆️ distress in domains of health burden, uncertainty, and finances, but no meaningful difference in physical/mental health vs general US population https://t.co/OKTJnfIcD1
-
-
Mashup Score: 0PIK3CA-Related Overgrowth Syndrome (PROS) Explained - 1 year(s) ago
Guillaume Canaud, MD, PhD, of the Paris Descartes University, provides an overview of PIK3CA-related overgrowth syndromes (PROS).
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Guillaume Canaud, MD, PhD, of Necker-Enfants Malades Hospital – AP-HP, the Paris Descartes University, provides an overview of PIK3CA-related overgrowth syndromes, a group of rare disorders caused by PIK3CA gene mutation. #PROS https://t.co/KRNliSBxwM
-
-
Mashup Score: 0Patient-reported outcome is associated with health care costs in patients with ischaemic heart disease and arrhythmia - 1 year(s) ago
AbstractAims. Systematic use of patient-reported outcomes (PROs) have the potential to improve quality of care and reduce costs of health care services. We aime
Source: OUP AcademicCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Editors' choice article: @MoonsPhilip highlighting the importance of patient reported outcome #PROs, as they are associated with #healthcare costs: https://t.co/GW7VWxNwre @AarhusUni_int @escardio @ACNAPPresident @EditorEJCN #ACNAP @BorregaardBritt @MarielaAcunaM1 https://t.co/pu2VMYewcb
-
-
Mashup Score: 0PIK3CA-Related Overgrowth Syndrome (PROS) Explained - 1 year(s) ago
Guillaume Canaud, MD, PhD, of the Paris Descartes University, provides an overview of PIK3CA-related overgrowth syndromes (PROS).
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Guillaume Canaud, MD, PhD, of Necker-Enfants Malades Hospital – AP-HP, the Paris Descartes University, provides an overview of PIK3CA-related overgrowth syndromes, a group of rare disorders caused by PIK3CA gene mutation. #PROS https://t.co/KRNliSBxwM
-
-
Mashup Score: 0Is Surgery a Good Option for Patients With PIK3CA-Related Overgrowth Syndrome (PROS)? - 1 year(s) ago
Dr Guillaume Canaud explains why surgery is usually not an effective treatment in the long-term for patients with PROS.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Guillaume Canaud, MD, PhD, of Necker-Enfants Malades Hospital – AP-HP, the Paris Descartes University, explains why surgical intervention to treat PIK3CA-related overgrowth syndromes #PROS is not always the best option. @PROS_PIK3CA @upemlv https://t.co/BtgAixGvdq
-
Understanding how patients with GVHD describe their health is crucial. Discover tools nurses can use to gather patient-reported outcomes in this insightful article by our contributor Elaine S DeMeyer, RN, MSN, AOCN, BMTCN. Read here: https://t.co/RnSjAKHh6o @PromisHealth #PROs https://t.co/oRenO4j2dV